Clinical Evidence: How Wegovy and Saxenda Compare in Trials
Wegovy vs Saxenda: Weight Loss Results from Clinical Trials
The most significant difference between Wegovy and Saxenda lies in their clinical trial outcomes for weight management. In the pivotal STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). Saxenda's SCALE trials demonstrated around 8% average weight loss at 56 weeks, representing substantial but comparatively lower outcomes than Wegovy's results.
However, these wegovy vs saxenda comparisons must be interpreted carefully, as the trials involved different study populations, timeframes, and methodologies. Both prescription-only medicines require clinical assessment to determine suitability, with individual results varying based on adherence to reduced-calorie diet and increased physical activity. UK patients considering either treatment should understand that clinical trial averages don't assurance personal outcomes, making professional prescriber guidance essential for realistic expectations.
Wegovy vs Saxenda Pricing: UK Treatment Costs Compared
When evaluating wegovy vs saxenda costs in the UK, Wegovy's pricing structure reflects its once-weekly dosing convenience. EverydayMeds offers Wegovy starting at £79.99 for the 0.25mg starter dose, progressing to £209.99 for the 2.4mg maintenance dose, with new customers applying code FIRST40 at checkout. Bundle options like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing two months of initial treatment in a single order.
Saxenda's daily administration typically results in different cost considerations, though both treatments require ongoing monthly investment for sustained weight management. Our Getting Started bundles offer convenience benefits rather than savings, ensuring patients maintain consistent supply throughout their dose escalation period. Returning customers can apply code DOSE25 at checkout, whilst both treatments qualify for next-day delivery following prescriber approval through our GPhC-registered pharmacy (#9012878).
STEP Trial Evidence: Wegovy's Clinical Performance Data
The comprehensive STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in weight management. STEP 3 demonstrated approximately clinically studied weight loss when combined with intensive behavioural therapy, whilst STEP 5 showed sustained clinically studied weight loss maintained at two years. These results position Wegovy among the most effective weight management medications available through UK prescription.
Most significantly, the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events among patients taking Wegovy, indicating benefits beyond weight loss alone. However, patients considering wegovy vs saxenda should remember that clinical trials represent controlled environments, with real-world results dependent on individual commitment to lifestyle modifications and consistent medication adherence.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in the intestine. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of satiety after smaller meals and potentially reducing food cravings throughout the day. The once-weekly injection provides sustained hormone activity, offering convenience advantages over daily treatments like Saxenda. Unlike Ozempic, which contains the same active ingredient but is licensed solely for type 2 diabetes, Wegovy is specifically formulated and licensed for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. This targeted approach requires combination with reduced-calorie diet and increased physical activity for optimal effectiveness.
Ordering Wegovy vs Saxenda Through EverydayMeds
Our streamlined ordering process applies equally to both wegovy vs saxenda consultations, beginning with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review each application within 3 working days (or 24 hours with express service), ensuring appropriate treatment selection based on individual circumstances. Once approved, both medications ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for medication stability and effectiveness. The assessment determines not only medication suitability but also appropriate starting doses and escalation schedules, with ongoing prescriber support available throughout treatment. This professional oversight ensures safe, effective weight management aligned with MHRA licensing requirements and NICE guidance recommendations.
Storage and Practical Considerations: Wegovy vs Saxenda
Wegovy's storage requirements offer practical advantages in the wegovy vs saxenda comparison, particularly for patients with active lifestyles or frequent travel commitments. Once removed from refrigeration, Wegovy pens remain stable for up to 6 weeks at room temperature below 30°C, compared to shorter room temperature periods for many competing treatments. The FlexTouch pen system provides user-friendly injection experience, with clear dose windows and simple operation suitable for patients new to injectable medications. Dose escalation follows a structured 16-week schedule, progressing from 0.25mg through to 2.4mg maintenance dosing, with each increase designed to optimise effectiveness whilst minimising potential side effects. This systematic approach requires patient commitment but supports sustainable weight management outcomes when combined with dietary and exercise modifications.
UK Weight Loss Results: Real-World Wegovy vs Saxenda Outcomes
Beyond clinical trial data, UK patient experiences with wegovy vs saxenda reflect the importance of individualised treatment selection and realistic expectation setting. Weight management specialists across the UK report that patients achieving optimal results typically demonstrate consistent medication adherence, structured dietary modifications, and regular physical activity engagement. The NHS recognition of both treatments under specific circumstances indicates their established role in comprehensive obesity management, though access through NHS services remains limited.
Private prescription access through registered pharmacies like EverydayMeds enables broader patient access whilst maintaining essential clinical oversight and safety monitoring. UK patients report that realistic goal setting, understanding potential side effects, and commitment to long-term lifestyle changes significantly influence successful outcomes with either treatment option, emphasising that medication selection represents just one component of comprehensive weight management strategy.
Making Your Wegovy vs Saxenda Decision
Choosing between Wegovy and Saxenda requires careful consideration of dosing preferences, clinical evidence, and individual lifestyle factors that influence treatment adherence and success. Both prescription-only medicines are available through EverydayMeds following appropriate clinical assessment, with qualified prescribers helping determine the most suitable option based on medical history and weight management goals. New customers can apply code FIRST40 at checkout, whilst returning patients use code DOSE25 to access our competitive pricing structure. Our next-day delivery service ensures prompt treatment initiation following prescriber approval, supported by ongoing clinical guidance throughout your weight management journey with complete confidence in our GPhC-registered pharmacy credentials.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
